In the same pathology, the increase in expression and activity of BiP and the IRE1α/XBP1 pathway were found to be essential for cell survival and pharmacological inhibition of IRE1α RNAse domain by the drug STF-083010 reduced the proliferation and survival of patient-derived pre-B ALL cells [155]. The gene discussed is ERN1; the disease is acute lymphoblastic leukemia.